Consistent with increased antigen presentation by uracil auxotroph invaded CD11c+ cells, antigen presenting cells harvested 18 h after uracil auxotroph vaccination of the ID8DV ovarian tumor microenvironment were previously shown to have regained a substantial ability to present the ovalbumin (OVA OT-I) peptide on MHCI for recognition by OVA-specific CD8+ T cells [16]. Here, CD8A is linked to ovarian neoplasm.